28155331
2017 Nov
We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-GantrezÂ® AN 119 Dox NPs of average size 220 nm with PDI
PLC/PRF/5 liver tumor; Pullulan; arabinogalactan; asialoglycoprotein receptor; doxorubicin hydrochloride; hepatocellular carcinoma.
